For example, it can detect BRCA1/BRCA2 mutations associated with breast and ovarian cancer risk, followed by mutations in genes such as TP53, known for its role in cell cycle regulation and apoptosis, and EGFR, which is relevant in developing non-small cell lung cancer. The gene discussed is BRCA2; the disease is ovarian carcinoma.